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Introduction: Carpal Tunnel Syndrome (CTS) is the most common and most well-known compression neuropathy which may manifest as 
mild, moderate, or severe and lead to various degrees of disability in people. The present study aimed to compare the effect of high-power diode 
laser beam and Transcutaneous Electrical Nerve Stimulation (TENS) separately and in combination on improvement of wrist pain and function 
in patients with CTS. Method and Materials: The study was designed as a randomized trial. A total of 45 patients (7 men and 38 women) were 
randomly divided into three groups of high-power laser (n=15), TENS (n=15), and high-power laser with TENS (n=15). The TENS group 
received conventional TENS on pain site for two weeks as 5 sessions per week and 30 minutes per session. The high-power laser group received 
6.5 J/cm2 laser for two weeks, five sessions per week. The group of high-power laser with TENS received conventional TENS and then 6.5 J/cm2 
laser for two weeks as five sessions per week and 30 minutes per session. The Persian McGill Pain Questionnaire, Visual Analogue Scale (VAS), 
and the 5-point scale of pain severity of McGill Pain Questionnaire (pain severity) were used to assess pain and the Persian version of the 
Disabilities of Arm, Shoulder, and Hand (DASH) questionnaire was administered to evaluate hand function before and after treatment. All the 
patients filled a demographic questionnaire including age, height, and weight prior to the intervention. Results: The mean scores of McGill, 
VAS, pain severity, and DASH questionnaires reduced significantly in high-power laser and high-power laser with TENS groups; however, these 
variables had no significant difference in the TENS group. Conclusions: High-power laser diode (808 nm, 6.5 j/cm2) can reduce pain and 
improve hand function in patients with mild to moderate CTS. Laser-induced anti-inflammatory effects and blood flow improvement are 
possible causes of decreased pain and sensory signs followed by improvement in hand function. 
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Carpal Tunnel Syndrome (CTS) is the most common and most 
well-known compression neuropathy which may manifest as mild, 
moderate, or severe and lead to various degrees of disability in 
people. Timely treatment of the disease will result in complete 
recovery while delayed treatment may bring irreparable effects (1). 
Clinical symptoms of the disease are seen more in women than in 
men (2) and include paresthesia, pain, and weakness in muscles 
innervated by median nerve (3, 4). The symptoms are caused due to 
compression of the median nerve at the wrist resulting in reduced 
blood flow (5), which usually intensifies at night (3, 4). CTS is a 
multifactorial disease, often with an unknown cause (5, 6). Its 
incidence is 1% in the general population and occurs commonly in 
older ages (7). There is no agreement regarding the primary 
treatment of CTS as surgery or noninvasive (conservative) (8-13). 
Non-invasive treatments of CTS include Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs), local injection of steroids, 
splinting, modification of activities, nerve and tendon gliding 
exercises, and the use of physiotherapy modalities such as 
iontophoresis, ultrasound, TENS, and laser therapy (13-20). 
The use of high-power laser has recently been highlighted in 
physiotherapy. As an advantage, this laser can penetrate deeper 
than low-power lasers and can stimulate large and deep joints to 
which low-power laser beams can hardly reach (21). 
Accordingly, it seems that more energy is transferred into tissues  
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Table 1. Inclusion/Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
- Patient≥18 years of age 
- Relevant Symptoms (Pain and/or numbness) for at least 
two fingers of one hand (thumb, index, middle, or ring 
finger) for less than one year 
- Mild to moderate CTS based on NCS results  
- No thenar atrophy  
- Patient with evidence of severe CTS  
- Thenar atrophy   
- Any previous hand or wrist surgery 
- Metabolic diseases (Diabetes mellitus, thyroid or kidney problem)  
- Diffuse peripheral neuropathy 
- Cervical radiculopathy 
- Brachial plexopathy 
- Proximal median neuropathy 
- Any known mass, tumor or deformity of the wrist 
- Any history of severe trauma to the wrist 
- Pregnancy or location 
- Connective tissue disorders or arthritis involving hand or wrist 
- Tenosynovitis 
- Fibromyalgia or other musculoskeletal disorders 
- All patients whose type of employment could be a risk factor on CTS, such 
as secretaries  
 
Table 2. Grading of CTS according to electrodiagnostic findings 
Grade Number Electrodiagnostic Findings  
Grade 0 Normal 
Grade 1 (very mild) CTS demonstrable only with most sensitive tests 
Grade 2 (mild) Slow median DSL, slow sensory nerve conduction velocity, normal terminal motor latency 
Grade 3 (moderate) Sensory potential preserved with motor slowing, distal motor latency to Abductor Pollicis Brevis (APB) < 6.5 ms 
Grade 4 (severe) Sensory potential absent but motor response preserved, distal motor latency to APB < 6.5 ms 
Grade 5 (very severe) Terminal latency to APB<6.5 ms 
Grade 6 (extremely severe) Sensory and motor potentials effectively un-recordable (surface motor potential from APB < 0.2 mV amplitude) 
 
Table 3. Demographic characteristics of the participants in the three groups of TENS, high-power laser, and high-power laser with TENS 
Variable 
Groups mean (SD) Minimum Maximum 
TENS Laser Laser+TENS TENS Laser Laser+TENS TENS Laser Laser+TENS 
Age 8.62 (52) 53.6(8.59) 48.60 (9.40) 36 37 35 73 66 62 
Weight 52 (8.62) 68.8(9.05) 60.63 (11.69) 59 54 47 88 85 91 
Height 166.53 (9.71) 166.44(5.28) 165.26 (9.33) 150 155 152 180 170 182 
 
Table 4. Changes in mean pain score 
Group Variable 
Stage 
Sig Baseline After intervention 
Mean (SD) Mean (SD) 
TENS 
McGill 33.3 (12.90) 29 (15.91) 0.066 
VAS 6.03 (2.582) 5.61 (2.58) 0.210 
Pain severity 3.00 (1.363) 2.60 (1.18) 0.082 
TENS + laser 
McGill 31.73 (13.82) 23.20 (13.00) 0.000 
VAS 6.61 (2.98) 3.03 (2.15) 0.000 
Pain severity 3.47 (1.59) 1.27 (0.594) 0.000 
High-power laser 
McGill 31.47 (12.44) 21.93 (9.40) 0.006 
VAS 6.93 (2.23) 4.57 (2.07) 0.000 
Pain severity 3.20 (1.01) 2.07 (0.961) 0.000 
 
Table 5: Changes in wrist function 
Group Variable Stage Sig 
Baseline After intervention 
Mean Mean 
TENS DASH 52 (17.028) 43.18 (17.50) 0.093 
TENS+laser DASH 54.81 (19.32) 30.40 (14.04) 0.002 
High-power laser DASH 56.72 (11.86) 39.81 (19.20) 0.002 
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Figure 1. Location of the TENS electrodes 
 
during treatment with high-power laser in comparison with 
low-power laser (22). Few studies have discussed anti-
inflammatory, anti-edema, and analgesic effects of high-power 
laser to justify its use for pain (23-24). 
Multiple methods used in the studies such as different types 
of lasers, different intensities, variables under study (outcome 
measures), different results, and different times of evaluation 
after treatment have made difficult the comparison and 
summarizing the information obtained from these studies to 
examine the impact of high-power laser beams in the treatment 
of CTS (25). The present study aimed to compare the effect of 
high-power diode laser beam and Transcutaneous Electrical 
Nerve Stimulation (TENS) separately and in combination on the 
improvement of wrist pain and function in patients with CTS. 
Methods and Materials 
The study was designed as a randomized experimental research.  
The medical ethics committee at the Tehran University of 
Medical Sciences approved the study ethics and issued the ethics 
certification number as IR.TUMS.REC.1395.2337, plan code: 
9211675008. Differential Diagnosis was performed by a 
neurologist through neurological signs and symptoms. The 
patients diagnosed with mild to moderate CTS were selected 
based on clinical symptoms and electrodiagnostic findings. 
Then, a physical therapist (candidate for doctoral level) 
evaluated the patients and recruited appropriate candidates for 
the study based on import/exodus criteria (Table 1). The grades 
of the CTS were scrutinized using electrodiagnostic findings as 
the grades 0-3 were mild to moderate and grades 4-6 were 
identified as severe (26) (Table 2). Two professional individuals 
carried out the initial assessments and recruitment evaluations. 
In the first step, the study was explained to the patients and 
those who accepted to attend were asked to sign a complete 
consent form. Inclusion criteria were 18 years of age or older, pain 
and paresthesia in at least two fingers of one hand (thumb, index, 
or middle finger), and lack of thenar atrophy. The patients were 
excluded from the study if they demonstrated any of following  
 
Figure 2. Location and the method of laser radiation 
 
disorders: thenar atrophy, any type of surgery on wrist and/or 
hand, history of wrist fracture, metabolic diseases (diabetes and 
thyroid and kidney diseases), peripheral neuropathy, neck 
radiculopathy, plexopathy and neuropathy of median nerve, 
pregnancy, lactation, connective tissue diseases, wrist and hand 
arthritis, tenosynovitis, and fibromyalgia (25). 
A total number of 45 patients (38 women and 7 men) were 
randomly divided, using the table of random numbers, into three 
groups of trials including: Groups of TENS (n=15; 10 women, 5 
men), high-power laser (n=15; 15 women, no man), and high-
power laser with TENS (n=15; 13 women, 2 men). All the 
participants completed the McGill Pain Questionnaire, the Visual 
Analogue Scale (VAS), the pain severity questionnaire, and 
Disabilities of Arm, Shoulder, and Hand (DASH) questionnaire 
prior to the study and immediately after the last session. 
The McGill pain questionnaire was applied to identify the level 
of pain. This pain rating index contains 78 pain descriptor items 
categorized into 20 subclasses, each containing 2-6 words that fall 
into 4 major subscales: dimensions of sensory (subclasses 1-10), 
affective and emotional (subclasses 11-15), evaluation-cognitive 
(subclass 16), and a miscellaneous group (subclasses 17-23). A 5-
point group of pain severity scale was used, as well (27). This 
questionnaire was previously translated into Persian and validated 
by Khosravi et al. in 2013 (28). To evaluate pain severity, the 
Persian McGill Pain Questionnaire, VAS, and the 5-point scale of 
pain severity of McGill Pain Questionnaire (pain severity) were 
used. The VAS is a 10-cm, non-graded horizontal line with fixed 
boundaries from no pain to worst possible pain, on which the 
patient marks his/her pain severity (29). The Persian version of 
the DASH questionnaire was administered to identify the 
performance in patients with CTS. DASH questionnaire is a well-
known functional reliable validated questionnaire, which can be 
applied to assess function for upper extremities. The 
questionnaire was translated and validated into many languages 
including Farsi (30). It is a 30-item questionnaire designed to 
measure physical function and symptoms in patients following 
upper extremity musculoskeletal disorders. (31) The score of the 
questionnaire can be used to estimate the disability level for  
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Figure 3. Demographic characteristics of the participants in the three groups of TENS, high-power laser, and high-power laser with TENS 
 
Figure 4. Changes in mean pain score 
 
shoulder, elbow, wrist, and/or fingers. The researchers in the 
present study monitored changes in patients’ symptoms and 
performances during the trial time and through the research 
purposes (32-35). 
The TENS group received conventional TENS (100 Hz, 80 
ms) lower than muscle contraction intensity for two weeks as 5 
sessions per week and 30 minutes per session. One electrode was 
placed over the transverse ligament and the other 10 cm above, 
over the median nerve pathway (36-37) (Figure 1). 
Transcutaneous electric current was applied using a TENS 
device (model ES-420, ITO, Japan) calibrated by the 
manufacturer prior to running the study. 
The high-power laser group received high-power diode laser 
with continuous wave of 3.2 Watts, maximum peak power of 600 
Watts, wavelength of 808 nm, and at a dose of 6.5 J/cm2 on two 
points of 2 cm2 over the transverse ligament for two weeks as 5 
sessions per week and 7 seconds per sessions (37) (Figure 2). The 
following formula was used to calculate the amount of the 
energy received (38-40). 
Energy (Joule) = Power (watt) × Time (second) × Duty cycle 
The Lumia 3plus laser device (Fisioline, Italy) was used to 
apply high-power laser beams. All devices were calibrated prior to  
TENS Laser Laser +
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TENS Laser Laser +
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TENS Laser Laser +
TENS
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Figure 5. Changes in wrist function 
running the study. The group of high-power laser with TENS 
received conventional TENS (similar to the TENS group) for two 
weeks as 5 sessions per week and 30 minutes per session followed 
by laser (similar to the high-power laser group) for 7 seconds. 
Results 
The demographic characteristics of patients in the three groups are 
shown in Table 3 and Figure 3. The Kolmogorov-Smirnov showed 
that patients had a normal distribution in all the three groups of 
high-power laser, TENS, and high-power laser with TENS. 
Results of McGill, VAS, and pain intensity questionnaires 
The mean changes in McGill, VAS, and pain intensity scores 
in the groups are presented in Table 4 and Figure 4. The means 
of these changes in all three groups were evaluated before and 
after treatment using paired t-test and the results showed that 
the mean scores of McGill, VAS, and pain intensity in the high-
power laser group and the high-power laser with TENS group 
significantly reduced after treatment. But these changes had no 
significant decrease in the TENS group. 
Results of DASH questionnaire 
The mean changes in DASH score in different groups are 
presented in Table 5 and Figure 5. The scores of all groups were 
evaluated before and after treatment using paired t-test and the 
results showed that the mean DASH score in the high-power 
laser group and the high-power laser with TENS group 
significantly reduced while these changes had no significant 
decrease in the TENS group (P=0.093). 
Discussion 
CTS is the most common compression neuropathy and the most 
common cause of hand pain (1). The disease is more prevalent 
in women than in men (2). CTS is diagnosed according to 
patients’ complaints and clinical symptoms such as weakness 
and muscle atrophy as well as electrophysiology studies (41). 
Treatment of the syndrome can vary from non-invasive 
methods with medication and exercise to surgical treatments 
(42). There is no agreement regarding the primary treatment of 
CTS as surgery or noninvasive (8, 11-13). Studies show that 
symptoms of 43-90% of patients persist after surgery, and 
symptoms are not reduced in one of every five persons (43-44). 
Therefore, it can be stated that the minimally invasive treatment 
is the first treatment of CTS and involves NSAIDs, local 
injection of steroids, splinting, modification of activities, nerve 
and tendon gliding exercises, and the use of physiotherapy 
modalities such as iontophoresis, ultrasound, TENS, and laser 
therapy (13-20). In vitro, laser therapy has a certain positive 
effect on nerve tissue, improvement of reconstruction and 
healing (9-10), and Schwann cells proliferation (11). These 
effects have been reported also in animal models with peripheral 
nerve damages and in human studies (12). 
The results obtained in the current study showed that high-
power diode laser beam (808 nm, 6.5 J/cm2) can significantly 
reduce pain in patients with mild to moderate CTS. In addition, 
combination of high-power laser and TENS significantly 
reduced pain in patients, while conventional TENS (100 Hz, 80 
ms) for 30 min did not considerably decrease pain. 
Casale et al. compared effects of TENS with high power laser 
therapy of a combined wavelengths of 808-1064 nm and 25 
Watts output power (18 Watts for 1064 nm and 7 Watts for 808 
nm). These researchers applied a total dose of 250 J/cm2 of high 
power laser irradiation over a 10 cm distance of median nerve 
and studied pain and electro physiological parameters in 
patients with mild to moderate CTS (36). They found that high-
power laser with the mentioned specifications significantly 
reduced the pain (P=0.024) and TENS had a near significant 
reduction of pain in these patients (P=0.047). It seems that the 
reason for the difference in the results of electrical stimulation 
in the mentioned study and the present research is the duration 
of intervention, despite the same treatment parameters. Casale 
et al. applied TENS in 15 sessions (three weeks, 5 sessions per 
week), while the modality in the present study was used in 10 
sessions (two weeks, 5 sessions per week). It seems that the use 
of transcutaneous electrical stimulation for a longer duration 
can somewhat relief pain in CTS patients. 
In the present study, the function of wrist in the high-power 
laser group and the high-power laser with TENS group 
significantly improved but there was no significant 
improvement in the TENS group. Various factors can affect 
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including pain, tingling, and anesthesia, nerve extension and 
gliding, nerve conductivity, and muscle strength (45). The 
effects of laser on nerve conduction velocity, distal latency of 
median nerve, and pain have been confirmed in several studies 
(46-50). In general, laser is capable of changing 
neurophysiologic parameters that can be evaluated and 
monitored usually in the compression of median nerve at wrist 
(50). This phenomena can justify the improvement of hand 
function in the high-power laser group and the high-power laser 
with TENS group. It seems that deep penetration of high-power 
laser beam is the reason for the higher effect of this modality in 
relieving pain in CTS. Although TENS blocks the entrance of 
pain receptors impulses to the spinal cord through thick nerve 
fibers (51), it has no identified effect on tissue inflammation and 
sensory nerve conduction velocity (52). 
Conclusion 
The current study showed that high-power laser diode (838 
nm, 6.5 j/cm2) can significantly reduce pain and improve 
hand function in patients with mild to moderate CTS at the 
end of ten treatment sessions. Therefore, it can be concluded 
that high-power diode laser is an effective and non-invasive 
method for the treatment of patients with CTS. Further 
clinical studies are required to prove this hypothesis. 
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